Annual EBITDA
-$6.03 M
-$189.13 M-103.29%
01 December 2023
Summary:
Sinovac Biotech annual earnings before interest, taxes, depreciation & amortization is currently -$6.03 million, with the most recent change of -$189.13 million (-103.29%) on 01 December 2023. During the last 3 years, it has fallen by -$228.14 million (-102.71%). SVA annual EBITDA is now -100.03% below its all-time high of $17.65 billion, reached on 31 December 2021.SVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly earnings before interest, taxes, depreciation & amortization is not available.SVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
N/A
01 June 2024
Summary:
Sinovac Biotech TTM earnings before interest, taxes, depreciation & amortization is not available.SVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -102.7% | - | - |
| 5 y5 years | -111.4% | - | - |
SVA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at low | ||||
| 5 y | 5 years | -100.0% | at low | ||||
| alltime | all time | -100.0% | +58.0% |
Sinovac Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$6.03 M(-103.3%) | - | - |
| Dec 2022 | $183.10 M(-99.0%) | - | - |
| Dec 2021 | $17.65 B(+7847.8%) | - | - |
| Dec 2020 | $222.11 M(+191.1%) | $199.95 M(+622.3%) | $222.11 M(+318.7%) |
| Sept 2020 | - | $27.68 M(+1367.0%) | $53.05 M(+28.3%) |
| June 2020 | - | $1.89 M(-125.4%) | $41.34 M(-33.8%) |
| Mar 2020 | - | -$7.42 M(-124.0%) | $62.43 M(-18.2%) |
| Dec 2019 | $76.29 M(+44.5%) | $30.90 M(+93.4%) | $76.29 M(+60.7%) |
| Sept 2019 | - | $15.98 M(-30.4%) | $47.46 M(-4.7%) |
| June 2019 | - | $22.97 M(+256.5%) | $49.81 M(+17.2%) |
| Mar 2019 | - | $6.44 M(+211.6%) | $42.51 M(-19.5%) |
| Dec 2018 | $52.79 M(+2.5%) | $2.07 M(-88.7%) | $52.79 M(+4.1%) |
| Sept 2018 | - | $18.32 M(+16.9%) | $50.72 M(+56.6%) |
| June 2018 | - | $15.67 M(-6.3%) | $32.40 M(+93.7%) |
| Mar 2018 | - | $16.73 M(+51.5%) | $16.73 M(+151.7%) |
| Dec 2017 | $51.49 M(+674.9%) | - | - |
| Dec 2016 | $6.64 M(-40.6%) | $11.04 M(+47.9%) | $6.64 M(-1940.7%) |
| Sept 2016 | - | $7.46 M(-161.7%) | -$361.00 K(-95.0%) |
| June 2016 | - | -$12.11 M(-5021.1%) | -$7.16 M(-163.5%) |
| Mar 2016 | - | $246.00 K(-93.9%) | $11.26 M(+0.6%) |
| Dec 2015 | $11.20 M(-19.2%) | $4.03 M(+501.2%) | $11.19 M(-23.8%) |
| Sept 2015 | - | $671.00 K(-89.4%) | $14.70 M(-9.6%) |
| June 2015 | - | $6.31 M(+3466.1%) | $16.26 M(+65.9%) |
| Mar 2015 | - | $177.00 K(-97.7%) | $9.80 M(-29.3%) |
| Dec 2014 | $13.86 M(-26.5%) | $7.54 M(+237.5%) | $13.86 M(-9.9%) |
| Sept 2014 | - | $2.23 M(-1629.5%) | $15.39 M(-16.8%) |
| June 2014 | - | -$146.00 K(-103.4%) | $18.49 M(-20.0%) |
| Mar 2014 | - | $4.24 M(-53.3%) | $23.11 M(+22.5%) |
| Dec 2013 | $18.85 M(-231.2%) | $9.07 M(+70.0%) | $18.87 M(+207.0%) |
| Sept 2013 | - | $5.33 M(+19.2%) | $6.15 M(-334.9%) |
| June 2013 | - | $4.47 M(<-9900.0%) | -$2.62 M(-69.5%) |
| Mar 2013 | - | -$4000.00(-99.9%) | -$8.58 M(-42.0%) |
| Dec 2012 | -$14.37 M(-245.5%) | -$3.66 M(+6.6%) | -$14.79 M(+446.0%) |
| Sept 2012 | - | -$3.43 M(+130.4%) | -$2.71 M(+297.8%) |
| June 2012 | - | -$1.49 M(-76.0%) | -$681.00 K(-111.2%) |
| Mar 2012 | - | -$6.21 M(-173.7%) | $6.11 M(-40.3%) |
| Dec 2011 | $9.88 M | $8.42 M(-700.4%) | $10.23 M(-200.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$1.40 M(-126.5%) | -$10.21 M(+26.3%) |
| June 2011 | - | $5.30 M(-353.3%) | -$8.09 M(-15.1%) |
| Mar 2011 | - | -$2.09 M(-82.6%) | -$9.52 M(+20.6%) |
| Dec 2010 | -$7.90 M(-117.8%) | -$12.01 M(-1768.2%) | -$7.90 M(-134.4%) |
| Sept 2010 | - | $720.20 K(-81.4%) | $22.93 M(-35.0%) |
| June 2010 | - | $3.87 M(-928.0%) | $35.28 M(-17.3%) |
| Mar 2010 | - | -$466.80 K(-102.5%) | $42.64 M(-3.8%) |
| Dec 2009 | $44.33 M(+151.3%) | $18.81 M(+43.8%) | $44.33 M(+50.8%) |
| Sept 2009 | - | $13.07 M(+16.5%) | $29.39 M(+53.5%) |
| June 2009 | - | $11.22 M(+817.6%) | $19.15 M(+24.8%) |
| Mar 2009 | - | $1.22 M(-68.4%) | $15.34 M(-13.3%) |
| Dec 2008 | $17.64 M(+18.6%) | $3.87 M(+36.7%) | $17.69 M(+1.3%) |
| Sept 2008 | - | $2.83 M(-61.9%) | $17.47 M(-8.1%) |
| June 2008 | - | $7.42 M(+108.0%) | $19.01 M(+28.3%) |
| Mar 2008 | - | $3.57 M(-2.2%) | $14.82 M(-15.4%) |
| Dec 2007 | $14.88 M(+771.0%) | $3.65 M(-16.6%) | $17.51 M(+528.9%) |
| Sept 2007 | - | $4.37 M(+35.2%) | $2.78 M(+23.7%) |
| June 2007 | - | $3.23 M(-48.3%) | $2.25 M(-328.2%) |
| Mar 2007 | - | $6.26 M(-156.5%) | -$986.50 K(-79.9%) |
| Dec 2006 | $1.71 M(-146.1%) | -$11.08 M(-388.5%) | -$4.90 M(+90.6%) |
| Sept 2006 | - | $3.84 M(<-9900.0%) | -$2.57 M(-40.5%) |
| June 2006 | - | -$4700.00(-100.2%) | -$4.33 M(-27.2%) |
| Mar 2006 | - | $2.34 M(-126.7%) | -$5.94 M(-14.3%) |
| Dec 2005 | -$3.70 M(-8.5%) | -$8.75 M(-519.1%) | -$6.93 M(-488.7%) |
| Sept 2005 | - | $2.09 M(-228.6%) | $1.78 M(-205.8%) |
| June 2005 | - | -$1.62 M(-220.2%) | -$1.69 M(+12.1%) |
| Mar 2005 | - | $1.35 M(-4538.5%) | -$1.50 M(-11.9%) |
| Dec 2004 | -$4.05 M(-2719.5%) | -$30.40 K(-97.8%) | -$1.71 M(-71.5%) |
| Sept 2004 | - | -$1.38 M(-4.0%) | -$5.99 M(+52.4%) |
| June 2004 | - | -$1.44 M(-225.6%) | -$3.93 M(+57.9%) |
| Mar 2004 | - | $1.15 M(-126.6%) | -$2.49 M(-31.5%) |
| Dec 2003 | $154.50 K(-499.2%) | -$4.31 M(-736.8%) | -$3.63 M(-636.8%) |
| Sept 2003 | - | $677.00 K | $677.00 K |
| Apr 2002 | -$38.70 K(-90.0%) | - | - |
| Apr 2001 | -$388.60 K(+11.3%) | - | - |
| Apr 2000 | -$349.30 K(+5273.8%) | - | - |
| Apr 1999 | -$6500.00 | - | - |
FAQ
- What is Sinovac Biotech annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Sinovac Biotech?
- What is the all time high quarterly EBITDA for Sinovac Biotech?
- What is the all time high TTM EBITDA for Sinovac Biotech?
What is Sinovac Biotech annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SVA is -$6.03 M
What is the all time high annual EBITDA for Sinovac Biotech?
Sinovac Biotech all-time high annual earnings before interest, taxes, depreciation & amortization is $17.65 B
What is the all time high quarterly EBITDA for Sinovac Biotech?
Sinovac Biotech all-time high quarterly earnings before interest, taxes, depreciation & amortization is $199.95 M
What is the all time high TTM EBITDA for Sinovac Biotech?
Sinovac Biotech all-time high TTM earnings before interest, taxes, depreciation & amortization is $222.11 M